Pulmonary Cell News 5.44 November 10, 2016 | |
| |
TOP STORYVasculogenic Mimicry in Small Cell Lung Cancer Researchers showed that small cell lung cancer (SCLC) patients have rare circulating tumor cells (CTC) subpopulations co-expressing vascular endothelial-cadherin (VE-cadherin) and cytokeratins consistent with vasculogenic mimicry, a process whereby tumor cells form ‘endothelial-like’ vessels. Single-cell genomic analysis reveals characteristic SCLC genomic changes in both VE-cadherin-positive and -negative CTCs. [Nat Commun] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Human Airway Organoid Engineering as a Step Toward Lung Regeneration and Disease Modeling Scientists combined human adult primary bronchial epithelial cells, lung fibroblasts, and lung microvascular endothelial cells in supportive 3D culture conditions to generate airway organoids. They demonstrate that randomly-seeded mixed cell populations undergo rapid condensation and self-organization into discrete epithelial and endothelial structures that are mechanically robust and stable during long term culture. [Biomaterials] Abstract Researchers determined the role of mitochondrial deacetylase, SIRT3 in transforming growth factor-β1 (TGF-β1)-induced myofibroblast differentiation in vitro and lung fibrosis in vivo. Treatment of human lung fibroblasts with TGFβ1 resulted in increased expression of fibrosis markers, smooth muscle alpha-actin, collagen-1 and fibronectin. [Am J Physiol Lung Cell Mol Physiol] Abstract Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4 Investigators aimed to assess the effects of human amnion epithelial cells-derived proresolution lipoxin-A4 on T-cell, macrophage, and neutrophil phenotype and function during the acute phase of bleomycin-induced lung injury. [Stem Cells Transl Med] Abstract Scientists describe a TNF-responsive element in an intronic region of ST3GAL4 gene, whose TNF-dependent activity is repressed by extracellular-signal-regulated kinase/p38 and mitogen- and stress-activated kinase 1/2 inhibitors. This TNF-responsive element contains potential binding sites for ETS1 and ATF2 transcription factors related to TNF signaling. They also show that ATF2 is involved in TNF responsiveness, as well as in TNF-induced ST3GAL4 BX transcript and sLex over-expression in A549 lung epithelial cells. [Biochem J] Abstract Investigators characterized particles from standard diesel, biodiesel in its neat form and 30% by volume blend with diesel fuel, and neat hydrotreated vegetable oil. The concentration of polycyclic aromatic hydrocarbons and their derivatives in organic extracts was the lowest for NEXBTL100 and higher for biodiesel. They analyzed global gene expression changes in BEAS-2B cells following 4 hour and 24 hour treatment with extracts. [Int J Mol Sci] Full Article | Graphical Abstract LUNG CANCERLKB1 is a commonly mutated tumor suppressor in non-small cell lung cancer that exerts complex effects on signal transduction and transcriptional regulation. The authors developed a transcriptional fingerprint assay representing this phenotype. This assay was predictive of LKB1 functional loss in cell lines and clinical specimens, even those without detected sequence alterations in the gene. [Cancer Res] Abstract Researchers examined cell-surface receptors that may act as drivers of lung tumorigenesis. They report that the PROTOCADHERIN PCDH7 is overexpressed frequently in non-small cell lung cancer tumors where this event is associated with poor clinical outcome. [Cancer Res] Abstract Tumor microenvironment (TME) plays an active role in promoting tumor progression. To further understand the communication between TME and tumor cells, the authors aimed at investigating the involvement of CD44, a type I cell surface receptor, in the crosstalk between tumor cells and TME. [Oncogene] Full Article PF4 Promotes Platelet Production and Lung Cancer Growth Scientists identified platelet factor 4 (PF4, CXCL4) as an endocrine factor whose overexpression in tumors correlates with decreased overall patient survival. Furthermore, engineered PF4 over-production in a Kras-driven lung adenocarcinoma genetic mouse model expanded megakaryopoiesis in bone marrow, augmented platelet accumulation in lungs, and accelerated de novo adenocarcinogenesis. [Cell Rep] Full Article | Graphical Abstract IL-17 Promotes Angiogenic Factors IL-6, IL-8, and VEGF Production via Stat1 in Lung Adenocarcinoma The authors found that tumor microvessel density was positively associated with interleukin (IL)-17, IL-6, L-8, and vascular endothelial cell growth factor (VEGF) expression in human lung adenocarcinoma tissues, and it was increased in tumor tissues of A549-IL-17 cell-bearing nude mice. [Sci Rep] Full Article | |
| |
REVIEWSMyofibroblasts and Lung Fibrosis Induced by Carbon Nanotube Exposure In view of the apparent fibrogenic activity of carbon nanotubes (CNT) and the emerging role of myofibroblasts in the development of organ fibrosis, the authors discuss recent findings on CNT-induced lung fibrosis with emphasis on the role of myofibroblasts in the pathologic development of lung fibrosis. [Part Fibre Toxicol] Full Article Targeting the KRAS Pathway in Non-Small Cell Lung Cancer The authors provide an overview of the KRAS pathway in lung cancer and related therapeutic strategies under investigation. [Oncologist] Full Article Regeneration of the Aging Lung: A Mini-Review In this review, the authors examine aging as a process dependent on specific changes in molecular pathways within multiple lung cell populations. [Gerontology] Full Article Visit our reviews page to see a complete list of reviews in the pulmonary cell research field. | |
| |
INDUSTRY NEWSThe Case-Coulter Translational Research Partnership announced more than $1 million in funding and support for the 2016 cycle. Four projects were selected for full program funding. Projects range from diagnostic and screening technologies to cancer therapeutics. [Case Western Reserve University] Press Release Bristol-Myers Squibb Company and Infinity Pharmaceuticals, Inc. announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo in combination with Infinity’s IPI-549 in patients with advanced solid tumors. [Bristol-Myers Squibb] Press Release Weill Cornell Medicine and the New York Genome Center were recently awarded a federal grant from the National Cancer Institute (NCI) to support a joint cancer genomics data center for the research and clinical interpretation of tumors. The grant will provide funding of $490,000 per year over the next five years. [Weill Cornell Medicine] Press Release IBM Watson Health and the Broad Institute of MIT and Harvard today announced a research initiative aimed at discovering the basis of cancer drug resistance. The five year, $50 million project will study thousands of drug resistant tumors and draw on Watson’s computational and machine learning methods to help researchers understand how cancers become resistant to therapies. [Broad Institute] Press Release | |
| |
POLICY NEWSThe Quiet Rise of the NIH’s Hot New Metric Biomedical funders worldwide are adopting the US agency’s free Relative Citation Ratio to analyze grant outcomes. [Nature News] Press Release Donald Trump’s US Election Win Stuns Scientists Republican businessman and reality-television star Donald Trump will be the United States’ next president. Although science played only a bit part in this year’s dramatic, hard-fought campaign, many researchers expressed fear and disbelief as Trump defeated former secretary of state Hillary Clinton. [Nature News] Press Release
| |
EVENTSNEW 2017 European Cancer Congress Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESPostdoctoral Research Fellow – Cancer GeneticsEpigenetics (Fred Hutchinson Cancer Research Center) Postdoctoral Researcher – Lung Cancer (Northwestern University) Postdoctoral Fellow – Lung Biology (Boston University) Cell Biologist – Pulmonary Vascular Signaling (University of Maryland) Research Fellow(s) – Pulmonary Research (Imperial College London) Postdoctoral Position – Virus-Induced Lung Repair (Max Planck Institute for Heart and Lung Research) Associate/Full Professor – Various Projects (University of California, San Francisco) Postdoctoral Training Fellow, Lung Cancer and Drug Resistance (Institute of Cancer Research) Professor Position – Pulmonary Cell Research (University of Pennsylvania) Postdoctoral Research Fellowship – Lung Disease (Johns Hopkins University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Pulmonary Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Pulmonary Cell News Volume 5.44 | Nov 10 2016